1 / 8

"Cancer/Tumor Profiling Market Expected to Reach $82,447 Million by 2023 "

Cancer Tumor Profiling Market study provides an in-depth analysis along with the current trends and future estimations of the global cancer/tumor profiling market to elucidate the imminent investment pockets. Comprehensive analyses of the factors that drive and restrict the market growth are provided in the report. The quantitative analysis of the industry for the period of 2016 to 2023 is provided to enable stakeholders to capitalize on the prevailing market opportunities.<br>

srushtih123
Télécharger la présentation

"Cancer/Tumor Profiling Market Expected to Reach $82,447 Million by 2023 "

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Key Growth Factors and Future Scope of the Cancer/Tumor Profiling Market Global Opportunity Analysis and Industry Forecast, 2017-2023

  2. Cancer/Tumor Profiling Market “The demand for cancer profiling methods has witnessed significant growth over the years with seamlessly integrating next-generation sequencing (NGS) and in-situ hybridization for cancer profiling. In addition, cancer profiling for the detection of molecular & genetic level of cancers, and use of personalized and targeted approaches for treatment have propelled the market growth.”

  3. Cancer/Tumor Profiling Market Overview Cancer/Tumor Profiling Market by Technology, Technique, and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global cancer/tumor profiling market was valued at $25,318 million in 2016, and is projected to reach $82,447 million by 2023, growing at a CAGR of 18.4% from 2017 to 2023. The next-generation sequencing (NGS) segment accounted for one-fourth share of the global market in 2016. Access Full Summary at: https://www.alliedmarketresearch.com/cancer-tumor-profiling-market Cancer/tumor profiling assists in individualizing cancer treatment by providing useful information at the molecular or genetic level. This helps medical practitioners to design an appropriate treatment for patients suffering from cancer. This technique assists in studying an individuals cancer cells and in analyzing the genetic characteristics and unique biomarkers. The information obtained post cancer profiling is used to identify and create targeted therapies that are designed to work better for a specific cancer tumor profile. 

  4. Cancer/Tumor Profiling Market The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth. The impact of the driving factors is expected to surpass that of restraints. Moreover, increase in focus towards personalized medicine offer lucrative opportunities for the market growth.

  5. Cancer/Tumor Profiling Market Snapshot  The global cancer/tumor profiling market is segmented based on technology, technique, application, and region. Based on technology, it is classified into next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), microarray, and others. The in-situ hybridization segment is further categorized into fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). Based on technique, the market is classified into genomics, proteomics, epigenetics, and metabolomics. Based on application, it is divided into personalized medicine, diagnostics, biomarker discovery, prognostics, and research applications. The cancer/tumor profiling market is analyzed across four regions namely, North America, Europe, Asia-Pacific, and LAMEA.

  6. Key Benefits of Cancer/Tumor Profiling Market • The study provides an in-depth analysis along with the current trends and future estimations of the global cancer/tumor profiling market to elucidate the imminent investment pockets. • Comprehensive analyses of the factors that drive and restrict the market growth are provided in the report. • The quantitative analysis of the industry for the period of 2016 to 2023 is provided to enable stakeholders to capitalize on the prevailing market opportunities. • Extensive analysis of key segments of the industry is provided to understand the type of techniques and methods used across the globe. • Key market players and their strategies are analyzed to understand the competitive outlook of the market.

  7. Cancer/Tumor Profiling Market North America Europe Asia-Pacific LAMEA

  8. Cancer/Tumor Profiling Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/2717 Follow Us On

More Related